Development

Articles

The American Association of Pharmaceutical Scientists (AAPS) recognized researchers at the organization's 2009 Annual Meeting and Exposition in Los Angeles this week.

AAPS Announces Annual Awards, Names 2009 Fellows

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

The Society of Chemical Manufacturers and Affiliates (SOCMA) reported last week that the US Food and Drug Administration responded to the association's citizen petition relating to the inspection process of foreign drug-manufacturing facilities.

SOCMA Hails FDA Action on Citizen Petition Regarding Inspections

Lonza (Basel, Switzerland), the large contract manufacturer of small-molecule and biologic-based active pharmaceutical ingredients (APIs), announced last week a series of cost-cutting measures for the next 12 to 18 months.

Lonza Restructures, Plans Cost Reductions

In response to a request from the US Food and Drug Administration, the US Pharmacopeial Convention (USP) revised its standards for propylene glycol and sorbitol solution

USP Revises Excipient Standards to Limit Contamination

Company and People Notes: sanofi aventis forms pact with Micromet; Laureate Pharma adds members to its business team.

Week of Nov. 2, 2009: Eli Lilly Opens Biotech Center; Johnson & Johnson Announces Restructuring; PPD Acquires Chinese CRO; More...

Angie Drakulich was editorial director of Pharmaceutical Technology.

A panel of industry and regulatory experts, including FDA, discuss efforts to secure the global pharmaceutical supply chain. This article contains bonus online-exclusive material.

Sharing Supply-Chain Security

Michelle Hoffman, editorial director of Pharmaceutical Technology.

While Congress debates hundreds of healthcare plan proposals, perhaps we, the public, can get in the game too.

DIY Healthcare Reform

Functionalized supramolecular catalysts and an enantioselective route to unnatural amino acids are some recent developments.

Advancing Chiral Chemistry in API Synthesis

A recent book reminds readers that small-molecule chemistry has enabled advances in biotechnology.

Whatever Happened to Classical Chemistry?

FDA's Edwin Rivera-Martinez on dodging supply-chain challenges.

Ingredients